Los Angeles - (NewMediaWire) - November 22, 2021 - The Schall Law
Firm, a national
shareholder rights litigation firm, reminds investors of a class action lawsuit
against Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition
Corp. (“Ginkgo” or “the Company”) (NYSE: DNA, NASDAQ: SRNG) for violations of §§10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
U.S. Securities and Exchange Commission.
Investors who
purchased the Company's securities between May 11, 2021 and October 5, 2021,
inclusive (the ''Class Period''), are encouraged to contact the firm before January
17, 2022.
If you are a
shareholder who suffered a loss, click here to participate.
We also encourage you
to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite
2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of
charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class, in this
case, has not yet been certified, and until certification occurs, you are not
represented by an attorney. If you choose to take no action, you can remain an
absent class member.
According to the
Complaint, the Company made false and misleading statements to the market.
Ginkgo was almost completely dependent on related parties due to its failure to
earn significant revenues from third-party customers. The Company derived most
or all of its revenue from related parties it created or otherwise controlled.
The Company concealed its dependence on related parties by misclassifying and
underreporting related party revenues. Many of the Company’s new R&D
partners were undisclosed related parties. Based on these facts, the Company’s
public statements were false and materially misleading. When the market learned
the truth about Ginkgo, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm
represents investors around the world and specializes in securities class
action lawsuits and shareholder rights litigation.
This press release may
be considered Attorney Advertising in some jurisdictions under the applicable
law and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
SOURCE:
The Schall Law Firm